Skip to main content
logo
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
65.05
+5.77 (9.73%)
Nov 9, 2026, 4:00 PM EST - Market closed

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Single Cell Instruments Revenue
18.20M22.67M35.21M
Spatial Instruments Revenue
23.05M34.11M57.50M
Total Instruments Revenue
41.25M56.78M92.72M
Single Cell Consumables Revenue
371.27M363.21M372.31M
Spatial Consumables Revenue
165.36M143.98M121.12M
Total Consumables Revenue
536.63M507.18M493.43M
Services Revenue
37.01M32.73M24.32M
License and Royalty Revenue
3.69M46.14M321.00K
Revenue (Total)
618.58M642.82M610.79M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
United States Revenue
319.85M346.51M334.32M
North America (ex-United States) Revenue
13.39M12.26M13.45M
Europe, Middle East and Africa Revenue
169.04M161.72M159.76M
China Revenue
61.04M70.26M57.30M
Asia-Pacific (ex-China) Revenue
55.25M52.07M45.96M
Revenue (Total)
618.58M642.82M610.79M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cumulative Instruments Sold
8.05K7.04K
Total Consumables Reactions Sold
424.00K357.10K